Day: October 30, 2024

**Traditional Shaker-Style Apple Pie Recipe: A Timeless Classic**

The Shakers, a religious community known for their simple, functional, and beautiful craftsmanship, left an indelible mark on American culture. Their influence extended beyond furniture and architecture to the culinary world, where their recipes reflected the same values of simplicity, purity, and practicality. One of the most beloved contributions from the Shaker kitchen is the traditional Shaker-style apple pie.

This pie is a celebration of the apple in its purest form, with minimal ingredients that allow the natural sweetness and tartness of the fruit to shine. The recipe is straightforward, yet the result is a deeply flavorful and comforting dessert that has stood the test of time. Let’s dive into the history, ingredients, and step-by-step process of making this timeless classic.

### A Brief History of the Shakers and Their Culinary Traditions

The Shakers, formally known as the United Society of Believers in Christ’s Second Appearing, were a religious sect that originated in England in the 18th century and later settled in the United States. They were known for their communal lifestyle, celibacy, and devotion to simplicity and order. Their motto, “Hands to work, hearts to God,” was reflected in every aspect of their lives, including their cooking.

Shaker cooking was based on the principles of frugality, efficiency, and the use of fresh, local ingredients. They grew much of their own food and were known for their meticulous gardening practices. Their recipes were often simple but flavorful, relying on the natural taste of the ingredients rather than elaborate seasonings or techniques.

The Shaker-style apple pie is a perfect example of this philosophy. It uses just a few basic ingredients—apples, sugar, flour, butter, and spices—to create a dessert that is both humble and delicious.

### Ingredients for Shaker-Style Apple Pie

The beauty of this recipe lies in its simplicity. You don’t need any fancy ingredients or equipment—just fresh apples and a few pantry staples. Here’s what you’ll need:

#### For the Pie Crust:
– 2 ½ cups all-purpose flour
– 1 cup (2 sticks) unsalted butter, chilled and cut into small cubes
– 1 teaspoon salt
– 1 tablespoon sugar
– 6-8 tablespoons ice water

#### For the Filling:
– 6-7 medium-sized apples (a mix of tart and sweet varieties like Granny Smith, Honeycrisp, or Golden Delicious)
– ¾ cup granulated sugar
– 2 tablespoons all-purpose flour
– 1 teaspoon ground cinnamon
– ¼ teaspoon ground nutmeg
– 1 tablespoon lemon juice (optional, to balance sweetness)
– 2 tablespoons unsalted butter, cut into small pieces

#### For the Egg Wash (optional):
– 1 egg, beaten with 1 tablespoon of water
– 1 tablespoon coarse sugar for sprinkling (optional)

### Step-by-Step Instructions

#### 1. Prepare the Pie Crust
The first step in making a traditional Shaker-style apple pie is preparing the crust. The Shakers were known for their attention to detail, and a well-made, flaky pie crust is essential to this recipe.

– **Combine dry ingredients**: In a large mixing bowl, whisk together the flour, salt, and sugar.
– **Cut in the butter**: Add the chilled butter cubes to the flour mixture. Using a pastry cutter or your fingertips, work the butter into the flour until the mixture resembles coarse crumbs with pea-sized pieces of butter.
– **Add ice water**: Gradually add the ice water, one tablespoon at a time, mixing gently with a fork or your hands until the dough just comes together. Be careful not to overwork the dough.
– **Chill the dough**: Divide the dough into two equal portions, shape them into discs, wrap them in plastic wrap, and refrigerate for at least 30 minutes (or up to 2 days). This step ensures a flaky crust.

#### 2. Prepare the Apple Filling
While the dough is chilling, you can prepare the apple filling. The Shakers believed in using fresh, seasonal ingredients, and apples were a staple in their kitchens.

– **Peel and slice the apples**: Peel, core, and thinly slice the apples. Aim for slices that are about ¼ inch thick to ensure even cooking.
– **Mix the filling**: In a large bowl, toss the apple slices with sugar, flour, cinnamon, nutmeg, and lemon juice (if using). The flour helps thicken the juices released by the apples as they bake, while the spices add warmth and depth of flavor.

#### 3. Assemble the Pie
Now it’s time to bring everything together.

– **Roll out the dough**: On a lightly floured surface, roll out one of the chilled dough discs into a 12-inch circle.

**Brook Health and Linus Health Announce Partnership to Enhance Cognitive Care Assessment**

In a significant development aimed at improving cognitive health management, **Brook Health** and **Linus Health** have announced a strategic partnership to enhance cognitive care assessment. This collaboration brings together the strengths of both companies to provide more comprehensive and accessible tools for early detection, monitoring, and management of cognitive decline, including conditions such as dementia and Alzheimer’s disease.

### The Growing Need for Cognitive Health Solutions

Cognitive decline is a pressing global health issue, particularly as the population ages. According to the World Health Organization, over 55 million people worldwide are living with dementia, with nearly 10 million new cases being diagnosed each year. Early detection and intervention are critical in slowing the progression of cognitive impairment and improving the quality of life for individuals affected by these conditions.

However, cognitive health assessments are often underutilized due to a lack of accessible, scalable, and user-friendly tools. Traditional cognitive assessments can be time-consuming, require in-person visits, and may not be integrated into routine healthcare. This is where the partnership between Brook Health and Linus Health comes into play, offering a promising solution to these challenges.

### Brook Health: A Leader in Digital Health Management

Brook Health is a digital health company that specializes in providing personalized, data-driven health management solutions. Through its AI-powered platform, Brook Health offers users real-time insights and guidance on managing chronic conditions such as diabetes, hypertension, and cardiovascular disease. The company’s mission is to empower individuals to take control of their health by offering easy-to-use tools that integrate seamlessly into their daily lives.

Brook Health’s platform is designed to be highly accessible, offering users a mobile-first experience that can be used anywhere, anytime. By leveraging artificial intelligence and machine learning, Brook Health provides personalized recommendations based on users’ health data, enabling them to make informed decisions about their health.

### Linus Health: Pioneering Cognitive Health Assessments

Linus Health is a digital health company focused on transforming brain health through advanced AI-driven cognitive assessments. The company’s platform combines cutting-edge neuroscience with artificial intelligence to deliver quick, accurate, and scalable cognitive assessments that can be administered via digital devices such as smartphones and tablets.

Linus Health’s cognitive assessment tools are designed to detect early signs of cognitive decline, even before noticeable symptoms appear. By using digital biomarkers and AI-powered analytics, the platform can provide healthcare providers with actionable insights into a patient’s cognitive health, enabling earlier intervention and more personalized care plans.

### The Partnership: A Synergistic Approach to Cognitive Care

The partnership between Brook Health and Linus Health represents a powerful synergy between two innovative companies in the digital health space. By integrating Linus Health’s cognitive assessment tools into Brook Health’s platform, users will now have access to a comprehensive suite of tools for managing both physical and cognitive health.

This integration will allow individuals to seamlessly monitor their cognitive health alongside other chronic conditions, providing a more holistic view of their overall well-being. The partnership also aims to make cognitive assessments more accessible to a broader population, particularly those who may not have easy access to traditional healthcare settings.

### Key Benefits of the Partnership

1. **Early Detection of Cognitive Decline**: By incorporating Linus Health’s AI-driven cognitive assessments into Brook Health’s platform, users will have the ability to detect early signs of cognitive decline. This early detection is crucial for timely intervention and can help slow the progression of conditions such as Alzheimer’s disease.

2. **Comprehensive Health Management**: The integration of cognitive assessments into Brook Health’s platform allows users to manage both their physical and cognitive health in one place. This holistic approach provides a more complete picture of an individual’s overall health, enabling more personalized and effective care plans.

3. **Scalability and Accessibility**: Both Brook Health and Linus Health are committed to making healthcare more accessible. By offering cognitive assessments through a mobile platform, the partnership ensures that individuals can access these tools from the comfort of their own homes, reducing the need for in-person visits and making cognitive care more scalable.

4. **Data-Driven Insights**: The combination of Brook Health’s AI-powered health management platform and Linus Health’s cognitive assessment tools will provide users and healthcare providers with valuable data-driven insights. These insights can help guide treatment decisions, track progress over time, and identify areas where additional support may be needed.

5. **Empowering Individuals**: One of the key goals of this partnership is to empower individuals to take control of their cognitive health. By providing easy-to-use tools that integrate seamlessly into daily life, the partnership encourages proactive health management and promotes early intervention.

### Looking Ahead: The Future of Cognitive Health

As the global population continues to age, the need for innovative solutions to address cognitive decline will only grow. The partnership between Brook Health and Linus Health represents a forward-thinking approach to this challenge, combining the latest advancements in AI and digital health to create a more accessible, scalable, and

**AION Labs Launches AI-Powered Startup to Accelerate Discovery of Active Small Molecules**

In an exciting development for the pharmaceutical and biotechnology industries, AION Labs, a pioneering innovation lab, has announced the launch of a new AI-powered startup aimed at accelerating the discovery of active small molecules. This initiative represents a significant step forward in the use of artificial intelligence (AI) to streamline drug discovery processes, reduce costs, and ultimately bring life-saving treatments to market faster.

### The Role of Small Molecules in Drug Discovery

Small molecules are low molecular weight organic compounds that can easily enter cells and modulate biological processes. These molecules are the foundation of many drugs used to treat a wide range of diseases, including cancer, cardiovascular diseases, and infectious diseases. The discovery and development of active small molecules, however, is a complex and time-consuming process, often taking years of research and costing billions of dollars.

Traditionally, the discovery of small molecules has relied on high-throughput screening (HTS) methods, where thousands or even millions of compounds are tested against biological targets. While HTS has been successful in identifying potential drug candidates, it is resource-intensive and often produces a high number of false positives or inactive compounds. This inefficiency has driven the search for more effective methods of drug discovery, and AI has emerged as a promising solution.

### AION Labs: A Hub for AI-Driven Innovation

AION Labs is a unique innovation lab that brings together leading pharmaceutical companies, AI experts, and academic institutions to foster the development of cutting-edge technologies in drug discovery and healthcare. The lab was founded with the mission of harnessing the power of AI to solve some of the most pressing challenges in the pharmaceutical industry, including the discovery of new drugs.

By launching this new AI-powered startup, AION Labs is taking a bold step toward transforming the way small molecules are discovered. The startup will leverage advanced machine learning algorithms and computational models to predict the activity of small molecules against specific biological targets, significantly reducing the time and resources required to identify promising drug candidates.

### How AI is Revolutionizing Small Molecule Discovery

AI has the potential to revolutionize small molecule discovery by automating many of the steps involved in the process. Here are some of the key ways AI is being applied:

1. **Predictive Modeling**: AI algorithms can analyze vast amounts of chemical and biological data to predict how small molecules will interact with specific targets. This allows researchers to focus on the most promising compounds, reducing the need for extensive experimental testing.

2. **De Novo Drug Design**: AI can be used to design entirely new small molecules from scratch. By analyzing the structure of a biological target, AI can generate novel compounds that are likely to bind to the target and produce the desired therapeutic effect.

3. **Optimization of Lead Compounds**: Once a potential drug candidate has been identified, AI can help optimize its properties, such as improving its binding affinity, solubility, and stability. This can accelerate the process of turning a lead compound into a viable drug.

4. **Data-Driven Insights**: AI can analyze large datasets from previous drug discovery efforts to identify patterns and trends that may have been missed by human researchers. This can lead to the discovery of new drug targets or previously overlooked compounds.

### The Benefits of AI-Powered Drug Discovery

The integration of AI into the drug discovery process offers several key benefits:

– **Speed**: AI can drastically reduce the time it takes to identify and optimize small molecules, potentially cutting years off the drug development timeline.

– **Cost Efficiency**: By reducing the need for costly experimental testing, AI can lower the overall cost of drug discovery, making it more feasible to develop treatments for rare or neglected diseases.

– **Precision**: AI can improve the accuracy of predictions, leading to fewer false positives and a higher success rate in identifying active compounds.

– **Scalability**: AI-driven platforms can analyze vast amounts of data at a scale that would be impossible for human researchers, enabling the discovery of new drugs across a wide range of diseases.

### Collaboration and Innovation at the Core

The success of AION Labs’ AI-powered startup will depend on collaboration between multiple stakeholders, including pharmaceutical companies, AI experts, and academic researchers. By bringing together diverse expertise, AION Labs aims to create a synergistic environment where innovation can thrive.

One of the key partners in this initiative is **BioMed X**, a research institute that specializes in early-stage drug discovery. BioMed X will work closely with AION Labs to apply AI-driven approaches to the discovery of small molecules, with a focus on addressing unmet medical needs.

Additionally, AION Labs has established partnerships with leading pharmaceutical companies such as Pfizer, AstraZeneca, and Merck, which will provide valuable industry insights and resources to support the startup’s efforts.

### The Future of AI in Drug Discovery

The launch of AION Labs’ AI-powered startup marks an important milestone in the ongoing evolution of

# Slow Cooker Recipe for Classic Pernil: A Tantalizing Puerto Rican Pork Delight

Pernil, a classic Puerto Rican recipe, is a must-have at holiday festivities and family events. This juicy, slow-cooked pork shoulder is seasoned with a mix of spices and herbs that permeate the meat with deep flavors, making it a cherished favorite for many. Although traditional preparation involves roasting the pork in an oven, utilizing a slow cooker provides a practical and equally tasty option. This guide will take you through the steps to create a delectable Pernil in your slow cooker, allowing you to relish this iconic dish any day you choose.

## What Exactly is Pernil?

Pernil is a marinated, slowly-cooked pork shoulder, generally flavored with a combination of garlic, oregano, and various spices. This dish is noted for its crispy exterior and tender, moist meat. Within Puerto Rican culture, Pernil is typically enjoyed during festive occasions like Christmas, New Year’s, and special family festivities. It is often served alongside rice and beans, tostones (fried plantains), or a refreshing salad.

## Ingredients

To craft a classic Pernil in a slow cooker, you will require the following ingredients:

### For the Marinade:
– 1 head of garlic (approximately 10-12 cloves)
– 1 tablespoon of dried oregano
– 1 tablespoon of ground cumin
– 1 tablespoon of paprika (smoked or sweet)
– 1 teaspoon of black pepper
– 1 teaspoon of salt (adjust as necessary)
– 1/4 cup of olive oil
– 1/4 cup of white vinegar or sour orange juice (for a more authentic touch)
– 1 tablespoon of adobo seasoning (optional, for additional flavor)
– 4-5 pounds of pork shoulder (bone-in or boneless)

### For Cooking:
– 1 onion, quartered
– 1-2 bay leaves
– 1 cup of chicken broth or water

## Instructions

### Step 1: Prepare the Marinade
1. **Create the Garlic Paste**: In a food processor or using a mortar and pestle, mix the garlic cloves, oregano, cumin, paprika, black pepper, salt, olive oil, vinegar (or sour orange juice), and adobo seasoning. Blend until smooth.

2. **Marinate the Pork**: Generously rub the garlic mixture all over the pork shoulder, ensuring it fills all the crevices. For the best taste, cover the pork and refrigerate for at least 4 hours, preferably overnight.

### Step 2: Prepare the Slow Cooker
1. **Layer the Vegetables**: Position the quartered onion and bay leaves at the base of the slow cooker. This creates a flavorful foundation for the pork, helping to keep it moist while cooking.

2. **Add the Pork**: Place the marinated pork shoulder atop the onions in the slow cooker. Pour in the chicken broth or water for added moisture.

### Step 3: Cook the Pernil
1. **Set the Slow Cooker**: Cover the slow cooker and set it to low. Cook for 8-10 hours, or until the pork is tender and easily shreds with a fork. If you’re pressed for time, you can cook it on high for 4-6 hours, but low and slow yields the best taste and tenderness.

### Step 4: Crisp the Skin (Optional)
For an authentic finish, you may wish to crisp the skin of the pork after it cooks in the slow cooker. To do so:
1. **Preheat the Oven**: Heat your oven to 450°F (230°C).
2. **Transfer the Pork**: Carefully take the pork out of the slow cooker and set it on a foil-lined baking sheet.
3. **Crisp the Skin**: Place the pork under the broiler for 5-10 minutes, keeping a close eye to avoid burning. The skin should turn crispy and golden brown.

### Step 5: Serve
1. **Slice and Enjoy**: Allow the pork to rest for a few minutes before slicing. Serve it alongside your favorite sides, such as rice and beans, tostones, or a fresh salad.

## Tips for the Perfect Pernil
– **Opt for Quality Meat**: Select a well-marbled pork shoulder for superior flavor and tenderness.
– **Allow for Longer Marinade**: The longer the pork marinates, the more flavorful it will become. Aim for at least 12 hours if possible.
– **Customize Seasonings**: Feel free to tweak the spices in the marinade to fit your palate. Some enjoy a hint of heat with crushed red pepper flakes or hot sauce.

## Conclusion

Creating Pernil in a slow cooker is a wonderful way to savor this traditional Puerto Rican dish with minimal effort.

**Space-Based 3D Cell Studies Pave the Way for New Cancer Therapy Approaches**

In recent years, the exploration of space has transcended beyond the realms of planetary science and astronomy, venturing into the intricate world of cellular biology. One of the most promising areas of research emerging from space-based studies is the investigation of how cancer cells behave in microgravity. These studies are providing new insights into cancer biology and paving the way for innovative therapeutic approaches that could revolutionize cancer treatment on Earth.

### The Microgravity Environment: A Unique Laboratory

Microgravity, the condition in which objects appear to be weightless, is a fundamental feature of space. This environment offers a unique opportunity to study biological processes in ways that are impossible on Earth. In the absence of gravity, cells can grow in three dimensions (3D) more naturally, mimicking the way they would in the human body. On Earth, traditional cell cultures are often grown in two dimensions (2D) on flat surfaces, which can limit their ability to replicate the complex structures and behaviors seen in living tissues.

The International Space Station (ISS), orbiting about 400 kilometers above Earth, has become a floating laboratory for studying the effects of microgravity on human cells, including cancer cells. Researchers have been sending cancer cells to the ISS for over a decade, and the results have been nothing short of groundbreaking.

### 3D Cell Growth in Space: A Closer Look at Tumor Behavior

One of the most significant advantages of studying cancer cells in space is the ability to observe their growth in three dimensions. On Earth, gravity causes cells to settle and spread out in a flat layer, which can distort their natural behavior. In the microgravity environment of space, however, cells are free to float and interact with one another in a more natural, 3D configuration. This allows scientists to study how cancer cells form tumors, communicate, and respond to their environment in ways that more closely resemble what happens inside the human body.

For example, researchers have found that cancer cells grown in microgravity tend to form spheroids—three-dimensional clusters of cells that closely mimic the structure of tumors in the body. These spheroids provide a more accurate model for studying how cancer cells grow, invade surrounding tissues, and resist treatment. By comparing the behavior of cancer cells in microgravity with those grown in traditional 2D cultures on Earth, scientists can gain new insights into the mechanisms that drive cancer progression.

### Microgravity and Cancer Cell Behavior: Surprising Discoveries

One of the most surprising findings from space-based cancer research is the way microgravity affects cancer cell behavior. Studies have shown that in the absence of gravity, cancer cells often exhibit reduced growth rates and become less aggressive. For example, a 2017 study conducted aboard the ISS found that certain types of cancer cells, including thyroid and breast cancer cells, showed decreased proliferation and increased sensitivity to chemotherapy drugs when grown in microgravity.

This discovery has profound implications for cancer therapy. If scientists can identify the molecular pathways that are affected by microgravity, they may be able to develop new treatments that mimic these effects on Earth. For instance, drugs that target the same pathways could potentially slow down tumor growth or make cancer cells more vulnerable to existing treatments like chemotherapy and radiation.

### Space-Based Drug Testing: Accelerating the Search for New Therapies

In addition to studying cancer cell behavior, the ISS has also become a platform for testing new cancer drugs. The microgravity environment allows researchers to screen potential therapies more efficiently by observing how they interact with 3D cancer cell models. This approach can help identify promising drug candidates that may not have been detected using traditional 2D cell cultures.

One notable example is the work of the pharmaceutical company Merck, which sent a key cancer drug, pembrolizumab (Keytruda), to the ISS in 2019. The goal was to study how the drug interacts with 3D tumor models in microgravity and to explore whether the unique environment of space could reveal new insights into its mechanism of action. While the results of this experiment are still being analyzed, the potential for space-based drug testing to accelerate the development of new cancer therapies is clear.

### The Role of Space Agencies and Private Companies

The growing interest in space-based cancer research has attracted the attention of both government space agencies and private companies. NASA, the European Space Agency (ESA), and other international organizations have been instrumental in facilitating these studies by providing access to the ISS and funding for research projects.

Private companies are also playing a key role in advancing space-based cancer research. For example, SpaceX, founded by Elon Musk, has been a major partner in transporting scientific payloads to the ISS, including cancer cell experiments. Additionally, biotech companies like NanoRacks and Techshot are developing specialized equipment for conducting biological research in space, further expanding the possibilities for space-based cancer studies.

### Future Directions: Bringing Space-Based Discoveries Back to Earth

As space

**Interview with Andreessen Horowitz: Insights on Supporting Knownwell’s National Expansion**

In the fast-paced world of venture capital, few firms have the influence and insight of Andreessen Horowitz (a16z). Known for backing some of the most transformative companies in tech, including Facebook, Airbnb, and Coinbase, a16z has built a reputation for identifying and nurturing disruptive innovators. One of their latest investments, Knownwell, a rapidly growing healthcare company, is poised to make waves on a national scale. We sat down with a16z partners to discuss their involvement in Knownwell’s expansion and the broader implications for the healthcare industry.

### **The Knownwell Vision**

Knownwell, founded in 2020, has quickly gained traction as a healthcare provider focused on delivering personalized, data-driven care. Knownwell’s model emphasizes preventive care, leveraging technology to offer patients a more holistic and proactive approach to managing their health. The company’s mission is to reduce the burden of chronic diseases, improve patient outcomes, and lower healthcare costs by focusing on early intervention and continuous care.

As Knownwell prepares for national expansion, Andreessen Horowitz has stepped in to provide both financial backing and strategic guidance. The firm’s involvement is not just about capital; it’s about helping Knownwell scale its operations, refine its technology, and navigate the complexities of the healthcare landscape.

### **Why Knownwell?**

We asked a16z why they chose to invest in Knownwell, and the answer was clear: the firm sees immense potential in the company’s approach to healthcare.

“Knownwell is tackling one of the most pressing issues in healthcare today—chronic disease management,” said Julie Yoo, General Partner at Andreessen Horowitz and a leader in the firm’s healthcare investments. “Their model of using data to drive personalized care is not only innovative but necessary. We believe they are well-positioned to disrupt the traditional healthcare system, which is often reactive rather than proactive.”

Yoo went on to explain that Knownwell’s focus on prevention aligns with broader trends in healthcare, where there is a growing emphasis on value-based care. “The future of healthcare is about keeping people healthy, not just treating them when they’re sick. Knownwell is at the forefront of this shift.”

### **Supporting National Expansion**

Knownwell’s national expansion is no small feat. The company is looking to scale its operations across multiple states, which requires significant investment in infrastructure, technology, and talent. Andreessen Horowitz is playing a key role in helping Knownwell navigate these challenges.

“We’re not just writing a check and walking away,” said Jeff Jordan, another General Partner at a16z. “We’re working closely with the Knownwell team to ensure they have the resources and expertise they need to scale effectively. This includes everything from helping them recruit top talent to advising on regulatory compliance as they enter new markets.”

Jordan emphasized that a16z’s involvement goes beyond financial support. “We have a deep bench of experts in healthcare, technology, and operations who are working with Knownwell to ensure they can scale without losing the quality of care that makes them unique.”

### **The Role of Technology**

One of the key factors driving Knownwell’s success is its use of technology to deliver personalized care. The company leverages data analytics, artificial intelligence, and machine learning to create individualized care plans for patients. This allows Knownwell to identify potential health issues before they become serious, enabling early intervention and reducing the need for costly treatments down the line.

Andreessen Horowitz has a long history of investing in technology-driven companies, and they see Knownwell as a perfect fit for their portfolio.

“Technology is at the heart of what Knownwell does,” said Yoo. “Their ability to collect and analyze data in real-time allows them to provide a level of care that traditional healthcare providers simply can’t match. This is where we see the future of healthcare going, and we’re excited to be a part of it.”

Yoo also highlighted the importance of interoperability in healthcare technology. “One of the challenges in healthcare is that systems don’t always talk to each other. Knownwell is working to break down these silos and create a more integrated approach to care. This is something we’re very passionate about at a16z, and we’re supporting them in this effort.”

### **Challenges and Opportunities Ahead**

While Knownwell’s growth prospects are promising, there are also significant challenges ahead. The healthcare industry is highly regulated, and expanding into new states requires navigating a complex web of laws and regulations. Additionally, scaling a healthcare business while maintaining high standards of care is no easy task.

“We’re aware of the challenges, but we’re confident that Knownwell has the right team and the right approach to overcome them,” said Jordan. “One of the reasons we invested in Knownwell is because of their leadership. They have a deep understanding of the healthcare landscape and a clear vision for how to scale their business while maintaining the quality of care that

After months in the pipeline, it looks like the European Health Data Space (EHDS) is finally entering into force later this year. But what does this mean for your organisation? In this post, we focus on the change that has been generating all the headlines: a new pathway to access health data for secondary uses […]

The post EHDS Deep-Dive: New pathway for accessing health data (Part 2) appeared first on Healthcare & Life Sciences Blog.